June 16, 2017
Results of the General Shareholders’ Meeting held on June 16, 2017. Read the Press release
June 15, 2017
BIOPHYTIS selects SGS Life Science Services to conduct MACA-PK, clinical study of Macuneos in dry AMD. Read the Press Release
May 18, 2017
Participation of Biophytis to Bio€quity Europe 2017. May 22-23, 2017. Marriott Rive Gauche, Paris, France
May 16, 2017
Biophytis announces the issuance of a €3 million tranche of ORNANEBSA. Read the Press Release
May 11, 2017
First patient-in in the United States and opening of 2 clinical centers for the SARA-OBS study on Sarcopenia. Read the Press Release
May 03, 2017
BIOPHYTIS confirms that Sarconeos modulates the Renin-Angiotensin System and activates muscular metabolism in the SARA-PK clinical trial. Read the Press Release
April 04, 2017
Biophytis secures funding for phase 2B clinical trial in Sarcopenia, SARA-INT. Read the Press Release
March 27, 2017
Biophytis opens the first clinical centers in Europe and starts the recruitment of sarcopenic patients for SARA-OBS study. Read the Press Release
March 21, 2017
Biophytis to present four scientific studies at the International Conference on Frailty & Sarcopenia Research (ICFSR) in Barcelona. Read the Press Release